A clinical trial is the final hurdle before a new medicine is cleared for sale to the public. This is a very important undertaking because it proves to the regulating agencies that the new medicine is safe for human use and does what it's supposed to do. Since the medicine must be tested on human beings, the company manufacturing it must recruit willing participants to take part in the trial. Some drugs can only be tested on patients with particular diseases while others can be tested on healthy patients.
It's important that companies use the correct medical trial recruitment strategies so that questions of wrongdoings don't arise. A company can face serious problems if it recruits participants through unethical clinical trial recruitment strategies and informed consent is thus a very important aspect of ethical recruitment strategies. People should only sign up for clinical trials when they have received adequate information concerning the trial. Dissemination of information begins at clinical trials marketing. This marketing exercise informs the public of planned clinical trials that they might be interested in. It's not possible to reach adequate numbers of potential volunteers without medical trials marketing.
As has been observed, people willing to volunteer for clinical trials should only do so after receiving all the information they require. It is wrong to have people sign up for a clinical trial out of ignorance. The drug company intending to hold a clinical trial should provide the public with all the information it requires beginning at the clinical trials marketing stage. At the marketing phase the public needs general information such as criteria for eligibility, duration of the trial, venue of the trial, the agency conducting the trial, and how the participants and the public will benefit from the trial. Following extensive medical trials marketing, eligible people will begin making enquiries. The interested volunteers must be properly educated about the trial before they are given a chance to sign up.
Since patient recruitment is expensive and time-consuming, many companies are often tempted to use improper clinical trial recruitment strategies so as to quicken the process. Bad recruitment strategies can nevertheless cause problems down the road and so it is best to avoid them. Afraid of losing volunteers even before they sign up, a company could be tempted to downplay any unpleasant aspects of the trial and embellish the beneficial aspects – it's very wrong to do this. A company might conceal some important information like the possible side-effects of a drug leading the volunteers into thinking that the drug is harmless. The company could at the same time hype up the benefits of the drug to make it more attractive for people to sign up.
As part of ethical clinical trial recruitment strategies, volunteers need to be informed about their rights and obligations as participants in the clinical trial. For instance, patients must be told that they have the right to opt out if they find the going too tough for them. People can endure a lot of discomfort if they are not aware of their rights to quit.
Volunteers should be told the truth and nothing but the whole truth since they are risking their bodies for the benefit of the company. In addition, company representatives should always be on hand to respond to participants' queries.